baber/WOPTO huggingface dataset:
Patent AU-5278799-A (AU)
Title: Unsaturated 14,15-cyclopropanoandrostanes, method for the production thereof andpharmaceutical preparations containing said compounds
Inventor: RING SVEN
IPC: C07J53/00
Filed: 1999-06-18
Abstract: Described are new, unsaturated 14,15-cyclopropano-androstanes of general formula (I) and their pharmaceutically acceptable salts, a process for their production and pharmaceutical preparations that contain these compounds. The compounds are characterized by hormonal (gestagenic and/or androgenic) activity and may be used for hormone replacement therapy.
Patent AU-5462980-A (AU)
Title: Imidazo-and pyrimido-pyridoindoles
Inventor: GABOR
IPC: C07D471/14
Filed: 1980-01-15
Abstract: 1. Claims for the Contracting States : BE, CH, DE, FR, GB, IT, LU, NL, SE. Imidazo and pyrimido-pyrido-indoles in form of racemates or enantiomers corresponding to formula (I)  see diagramm : EP0015786,P9,F1  wherein n is 1 or 0, R1 is a hydrogen or halogen atom, an alkyl or alkoxy radical or a CF3 group, R2 is an alkyl, cycloalkyl, cycloalkylalkyl, phenyl or benzyl radical, the two latter radicals being optionally substituted with a halogen atom or an alkyl or alkoxygroup, R3 is a hydrogen atom or an alkyl radical, R4 is a hydrogen atom or an alkyl radical, said alkyl and alkoxy radicals having 1 to 4 carbon atoms, with the exception of the compound for which n = 1, R1 = R3 = R4 = H and R2 = CH3 . 1. Claim for the Contracting State : AT A process for preparing imidazo and pyrimido-pyrido-indoles in form of racemates or enantiomers corresponding to formula (I)  see diagramm : EP0015786,P11,F3 wherein n is 1 or 0, R1 is a hydrogen or halogen atom, an alkyl or alkoxy radical or a CF3 group, R2 is an alkyl, cycloalkyl, cycloalkylalkyl, phenyl or benzyl radical, the two latter radicals being optionally substituted with a halogen atom or an alkyl or alkoxy group, R3 is a hydrogen atom or an alkyl radical, R4 is a hydrogen atom or an alkyl radical, said alkyl and alkoxy radicals having 1 to 4 carbon atoms, with the exception of the compound for which n = 1, R1 = R3 = R4 = H and R2 = CH3 , characterized in that a compound of formula (II)  see diagramm : EP0015786,P11,F4  is reacted with an amine R2 NH2 , then the intermediate compound obtained, of formula (III)  see diagramm : EP0015786,P12,F1  is cyclized by means of formaldehyde in 30% aqueous solution, and, when R4 = H, the corresponding compound (I) may be alkylated to yield a compound (I) wherein R4 is alkyl.
Patent AU-5463486-A (AU)
Title: Preparation of monolithis catalyst supports having an integrated high surface area phase
Inventor: DEANGELIS THOMAS PETER
IPC: B01J21/04
Filed: 1986-03-12
Abstract: A method of preparing a monolithic catalyst support having an integrated high surface area phase as provided. A plasticized batch of ceramic matrix material intimately mixed with high surface area powder is formed into the desired shape for the monolith and then heated to sinter the ceramic. The resulting monolith has a strong substrate of the ceramic matrix material and a high surface area phase provided by the high surface area powder extruded with the batch.
Patent AU-5534500-A (AU)
Title: Distortion detector
Inventor: ROTTNER FRANZ
IPC: G01D5/30
Filed: 2000-06-23
Abstract: A device for detecting different conditions of a component, such as distorted conditions, movements and loaded conditions. Said device comprises a transmitter and a receiver which are located independently on at least one component at a distance from one another and an evaluation unit. The transmitter emits an electromagnetic wave (such as e.g. a laser beam), or a focused particle beam to the receiver. The spatial resolution can be increased by multiple reflections from a mirror and a semi-transparent mirror.
Patent AU-5583700-A (AU)
Title: Connector assembly
Inventor: ERIKSSON JAN-OLOF
IPC: A61L2/26
Filed: 2000-06-09
Abstract: The present invention relates to a connector assembly (3) for connection to a container (1) for sterilising goods, preferably for pharmaceutical applications, and a releasable connector port (5) for releasably connecting said connector assembly (3) to a treatment station (1) for the goods that is contained in said container (1). Said connector assembly (3) further includes a second port that initially is provided with a detachable rapid transfer port cap (4), which cap (4) corresponds to a rapid transfer port means (15) that is provided at a goods transfer station (12). The connector port (5) and the rapid transfer port cap (4) are in fluid connection via a good stopper means (7). The invention also relates to a multi-treatment sterilising system and to a method for transferring sterilised goods from a multi-purpose container using a system according to the invention.
Patent AU-5959886-A (AU)
Title: Screening apparatus with integrated distributing and segregating device
Inventor: EGGERSTEDT KARL HEINZ
IPC: B07B1/46
Filed: 1986-05-30
Abstract: PCT No. PCT/SE86/00251 Sec. 371 Date Feb. 5, 1987 Sec. 102(e) Date Feb. 5, 1987 PCT Filed May 30, 1986 PCT Pub. No. WO86/07290 PCT Pub. Date Dec. 18, 1986.A screening apparatus of the multi-deck type. The feed inlet space of the screening machine comprises one or more distributing and segregating devices, integrated with the movement of the screening apparatus.
Patent AU-6434698-A (AU)
Title: Method and apparatus for cartilage growth stimulation
Inventor: RYABY JACK
IPC: A61B18/20
Filed: 1998-02-06
Abstract: A kit of elements including an ultrasonic generator (12), transducers (402) with connecting cables (407, 408), and a means (405, 406) for locating the transducers over areas of the body containing cartilage, is provided with the surgical instruments for post-surgical application to ultrasonically stimulate the cartilage growth, thus relieving the effects of surgical intervention.
Patent AU-6475600-A (AU)
Title: Antibiotic caprazamycins and process for producing the same
Inventor: TAKEUCHI TOMIO
IPC: C07H19/06
Filed: 2000-08-11
Abstract: There have been obtained, by cultivation of Streptomyces sp. MK730-62F2 (deposit number of FERM BP-7218), antibiotic caprazamycins A to F having by the following general formula (I) <CHEM> wherein R is tridecyl group, 11-methyl-dodecyl group, and others. These caprazamycins have excellent antibacterial activities against various acid-fast bacteria and various bacteria as well as their drug-resistant strains.
Patent AU-6481796-A (AU)
Title: Nucleotide and protein sequences of vertebrate delta genes and methods based thereon
Inventor: ISH-HOROWICZ DAVID
IPC: C07K14/47
Filed: 1996-06-28
Abstract: The present invention relates to nucleotide sequences of vertebrate Delta genes, and amino acid sequences of their encoded proteins, as well as derivatives (e.g., fragments) and analogs thereof. In a specific embodiment, the vertebrate Delta protein is a human protein. The invention further relates to fragments (and derivatives and analogs thereof) of Delta which comprise one or more domains of the Delta protein, including but not limited to the intracellular domain, extracellular domain, DSL domain, domain amino-terminal to the DSL domain, transmembrane region, or one or more EGF-like repeats of a Delta protein, or any combination of the foregoing. Antibodies to Delta, its derivatives and analogs, are additionally provided. Methods of production of the Delta proteins, derivatives and analogs, e.g., by recombinant means, are also provided. Therapeutic and diagnostic methods and pharmaceutical compositions are provided. In specific examples, isolated Delta genes, from Xenopus, chick, mouse, and human, are provided.
Patent AU-6542690-A (AU)
Title: Method for tagging articles used in conjunction with an electronic article surveillance system, and tags or labels useful in connection therewith
Inventor: GILL PETER L
IPC: G06Q10/00
Filed: 1990-10-04
Abstract: Electronic article surveillance (EAS) tags (20) are attached to articles of merchandise, not at the store (16) using EAS equipment (18), but in conjunction with the manufacture (10) of these articles. At that stage, the tags (20) are not detectable by the EAS equipment (18). They are made detectable upon receipt by an EAS-using store (16). For swept frequency RF EAS equipment (18), the tags (20) are initially provided with two capacitors (24, 25) which make the tags (20) resonant at a first frequency not detectable by the store's EAS equipment (18). To activate them, one capacitor (24, 25) is disabled, thereby making the tags (20) resonant at a different frequency which is detectable. <IMAGE>
Patent AU-6811900-A (AU)
Title: Non-corrosive catalytic hydrolysis of fatty acid esters to fatty acids
Inventor: SINNEMA JACOBUS
IPC: C07B61/00
Filed: 2000-08-21
Abstract: The present invention relates to a process for the direct hydrolysis of a fatty acid ester to the corresponding fatty acid and alcohol in the presence of a catalyst, wherein a compound of a metal that is capable of forming a soap with a large hydration shell is added as a catalyst.  <IMAGE>
Patent AU-7103996-A (AU)
Title: Meta-guanidine, urea, thiourea or azacyclic amino benzoic acid derivatives as integrin antagonists
Inventor: RUMINSKI PETER GERRARD
IPC: C07D249/14
Filed: 1996-08-27
Abstract: The present invention relates to a class of compounds represented by the Formula Ior a pharmaceutically acceptable salt thereof, whereinA ispharmaceutical compositions thereof and methods of using such compounds and compositions as alphavbeta3 antagonists.
Patent AU-7159698-A (AU)
Title: Improved automatic surgical device for cutting a cornea and a cutting blade assembly and control assembly therefor
Inventor: HELLENKAMP JOHANN F
IPC: A61B19/00
Filed: 1998-04-24
Abstract: A surgical device for cutting substantially across a cornea of an eye of a patient, the device including a positioning ring structured to be temporally attached to a portion of the eye surrounding the cornea to be cut, and defining an aperture sized to receive and expose the cornea to be cut. The surgical device further includes a cutting head assembly structured to be guided and driven over an upper surface of the positioning ring in a generally arcuate path, and having a cutting element positioned therein and structured to oscillate laterally to facilitate smooth and effective cutting of the cornea. The cutting head assembly is structured to be detachably coupled to the positioning ring by a coupling member which permits movement of the cutting head assembly relative to the positioning ring along the generally arcuate path, but maintains sufficient engagement therebetween to ensure that smooth, steady, driven movement is maintained <IMAGE>
Patent AU-7227794-A (AU)
Title: Use of cephem derivatives as anti-metastatic agents
Inventor: ALPEGIANI MARCO
IPC: C07D501/00
Filed: 1994-06-24
Abstract: PCT No. PCT/EP94/02059 Sec. 371 Date Mar. 8, 1995 Sec. 102(e) Date Mar. 8, 1995 PCT Filed Jun. 24, 1994 PCT Pub. No. WO95/02603 PCT Pub. Date Jan. 26, 1995The present invention relates to the use of known cephem derivatives of the formula:    <IMAGE>en or an organic radical, R2 represents halo or an organic radical or R1 and R2 taken together with the C-2 carbon atom of the cephem nucleus constitute a carbocyclic or heterocyclyl group; R3 represents R2 as defined above or an organic radical, R4 is either R1 or an organic group, R5 is either R1 as defined above or halo or C1-C6 alkoxy, C1-C6 alkylthio or C1-C6 acylamino; R6 is R2 as defined above or an organic group, or a pharmaceutically acceptable salts thereof.
Patent AU-7253191-A (AU)
Title: Quantitative analysis of chiroinositol as a diabetic condition predictor
Inventor: KENNINGTON ALISON S
IPC: G01N33/66
Filed: 1991-02-06
Abstract: An enhanced quantitative assay for chiro-inositol concentration can be used to determine insulin-resistance, or a predisposition to the development of insulin-resistance, in type I and type II diabetics. Spot urine or serum samples reflecting concentrations of chiro-inositol below about 1.0 micrograms/ml in urine or 0.1 micrograms/ml in serum are indicative of a predisposition to the development of insulin-resistance, while concentrations below about 0.3 micrograms/ml or 0.03 micrograms/ml in serum are associated with actual insulin-resistance symptoms. The assay can be employed for patient diagnosis, insulin therapy monitoring, and family screening.
Patent AU-7253501-A (AU)
Title: Transdermal therapeutic system for highly dispersed silicon dioxide
Inventor: KLOKKERS KARIN
IPC: A61J1/00
Filed: 2001-07-12
Abstract: In a transdermal therapeutic system (TTS) comprising an impermeable backing layer, one or more matrix layers (at least one of which is self-adhesive) containing active agent(s) (A) and a removable backing layer, highly dispersed silicon dioxide (I) is contained in the matrix layer(s) to increase permeation through the skin. Independent claims are included for two alternative forms of the TTS, in which: (a) the matrix layer(s) is/are coated with an adhesive layer (rather than being self-adhesive) and (I) is contained in the adhesive layer; or (b) the matrix layer(s) is/are replaced by an (A)-containing reservoir layer provided with a semipermeable membrane and an adhesive layer, (I) being contained in the adhesive layer.
Patent AU-7266796-A (AU)
Title: Modified kaolins
Inventor: SINGH BALBIR
IPC: B28C1/14
Filed: 1996-10-23
Abstract: PCT No. PCT/AU96/00667 Sec. 371 Date Apr. 15, 1998 Sec. 102(e) Date Apr. 15, 1998 PCT Filed Oct. 23, 1996 PCT Pub. No. WO97/15427 PCT Pub. Date May 1, 1997A process for the preparation of a modified kaolin from a kaolin group mineral which includes expansion and contraction of layers of the kaolin group mineral. The layers comprising one Si-tetrahedral sheet and one Al-octahedral sheet. The expansion and contraction may be initiated by initial intercalation of a reagent which can penetrate kaolin layers to reach an interlayer region therebetween to form an intercalate. Subsequently, the intercalation nay be followed by de-intercalation which involves the removal of the reagent. By the above process, there is provided crystalline modified kaolins having the following properties: (i) an increased interlayer space compared to corresponding kaolin group minerals; (ii) an increased susceptibility to intercalation by cations, anions or salts compared to corresponding kaolin group minerals; and (iii) an increased exfoliated morphology compared to corresponding kaolin group minerals.
Patent AU-7289887-A (AU)
Title: Method and device for pre-heating waste metal for furnaces
Inventor: GRANSTROEM STAFFAN
IPC: F27D13/00
Filed: 1987-04-15
Abstract: PCT No. PCT/SE87/00195 Sec. 371 Date Dec. 14, 1987 Sec. 102(e) Date Dec. 14, 1987 PCT Filed Apr. 15, 1987 PCT Pub. No. WO87/06331 PCT Pub. Date Oct. 22, 1987.This invention relates to a method and a device for pre-heating waste metal for furnaces, fuel gases generated in a furnace (1) being supplied simultaneously or sequentially to two pre-heating places (3, 4) with waste metal containers (14), said flue gases being made to flow through a combustion chamber (19) provided with a burner (20) before being supplied to the pre-heating places (3, 4), said burner (20) producing a variable amount of hot gases for admixture with the flue gases from the furnace (1) and superheating thereof. After flowing through the waste metal containers (14) burnt flue gases are supplied to a gas cleaning plant (5) for flue gases and unburnt flue gases to the combustion chamber (19) for further combustion, after which the flue gases now burnt are supplied to said gas cleaning plant (5).
Patent AU-7405398-A (AU)
Title: Mixed flow liquid ring pumps
Inventor: HAAVIK HAROLD K
IPC: F04D31/00
Filed: 1998-07-02
Abstract: A conically ported liquid ring pump has one or more port structures with cone angles in the range from 15 degrees to 75 degrees. These cone angles are substantially greater than previously used cone angles (most commonly about 8 degrees). The large cone angles of this invention give the fluid flowing between the cone and the rotor significant components of both radial and axial velocity. Large cone angles also allow the port structure(s) to be made axially shorter, which has a number of important advantages such as shortening the unsupported length of the rotor shaft. These attributes of the present pumps are helpful for such purposes as allowing the length-to-diameter ratios of the pumps to be economically increased. In addition, the pumps of this invention retain many of the desirable attributes of conically ported pumps. <IMAGE>
Patent AU-7691194-A (AU)
Title: Bacteriocins from (streptococcus thermophilus)
Inventor: GERMOND JACQUES-EDOUARD
IPC: A61K8/00
Filed: 1994-08-24
Abstract: The invention relates to two new Streptococcus thermophilus bacteriocins having the amino acid sequences SEQ ID NO:1 and SEQ ID NO:2, the signal peptides for these two bacteriocins, the nucleotide sequences encoding these bacteriocins especially an operon encoding the said bacteriocins having the sequence SEQ ID NO:3, the strains producing at least one of these bacteriocins, especially the strain CNCM 1-1351, a method for producing a supernatant extract comprising at least one of these two bacteriocins, and a use of these bacteriocins in the preparation of food products especially cheeses and acidified milks, and of cosmetic products as active agent against pathogens.
Patent AU-7776581-A (AU)
Title: Removing phosphorous impurities from yellowcake
Inventor: BROWN RICHARD ALEXANDER
IPC: C22B60/02
Filed: 1981-11-23
Abstract: Phosphorus impurities are removed from yellowcake by dissolving it in hydrochloric or sulfuric acid to a U3O8 assay of at least 150 g/l at a pH of 2; precipitating uranium peroxide with hydrogen peroxide while keeping the pH between 2.2 and 2.6 and recovering the uranium peroxide from the phosphorus impurities remaining in solution.
Patent AU-7927294-A (AU)
Title: Surge protector connector
Inventor: TELLAS RONALD L
IPC: H01R13/646
Filed: 1994-10-03
Abstract: A surge protector connector comprises a surge protector having a front plate, a rear plate, and hollow cylindrical body bridging the front and rear plates. A coaxial cable connector interface extends from the front plate, and the connector interface is constructed and arranged to detachably engage with a mating coaxial cable connector at the end of a first coaxial cable. A cable attachment interface extends from the rear plate, and the cable attachment interface is constructed and arranged to attach directly to a prepared end of a second coaxial cable free of another coaxial cable connector interface. The surge protector connector further includes coaxial inner and outer conductors extending through the hollow cylindrical body and extending between the cable attachment interface and the coaxial cable connector interface. The surge protector includes a curvilinear quarter-wavelength shorting stub having a first portion extending in a generally radial direction from the inner conductor through a gap in the outer conductor and a second portion extending in a generally annular direction circumscribing the outer conductor between the outer conductor and the cylindrical body. <IMAGE>
Patent AU-8019294-A (AU)
Title: Methodologies for extracting and using muira puama
Inventor: CHERKSEY BRUCE D
IPC: A23K10/32
Filed: 1994-10-18
Abstract: A method, and related compositions, for reducing body fat percentage, increasing lean muscle mass and/or lowering cholesterol levels in individuals. The method consists of the ingestion of an extract derived from muira puama root, bark or other wood material. A method of preparing the muira puama extract into an easily ingestible and manipulatable solid form, and pharmaceutical compositions for use by mammalian subjects, are also disclosed.
Patent AU-8104294-A (AU)
Title: New steroids with radical-attracting aromatic substituents, process for the production thereof and pharmaceutical compounds containing the said substances
Inventor: DROESCHER PETER
IPC: C07J41/00
Filed: 1994-11-08
Abstract: Novel substituted steroid compounds are disclosed which are more effective than known radical-trapping agents in methods of prophylaxis and therapy of radical-mediated cell damage and of treatment of diseases due to radical-mediated cell damage. The novel substituted steroid compounds can be made from steroids having an estrane, androstane, pregnane or cholestane basic skeleton and have a radical-attracting aromatic substituent of the general formula -(CH2)nX, or =CH-(CH2)mX at the 17 or 6 position of the steroid nucleus, wherein X=Y, OY, SY, SeY or NHY; n=0 to 5; m=n-1 and Y is a phenyl group having five substituents A, B, C, D and E, wherein A to E is independently H, alkyl, Oalkyl, Oacyl, OH, or one of the substituents B, C or D is NR2 wherein R=alkyl and each of the other substituents is hydrogen. Pharmaceutical compositions containing the novel substituted steroid compounds and methods of making them are also part of the invention.
Patent AU-8336591-A (AU)
Title: Sheet-wound coils
Inventor: FORSBERG ERIK
IPC: H01F27/28
Filed: 1991-07-01
Abstract: PCT No. PCT/SE91/00471 Sec. 371 Date Jan. 6, 1993 Sec. 102(e) Date Jan. 6, 1993 PCT Filed Jul. 1, 1991 PCT Pub. No. WO92/02941 PCT Pub. Date Feb. 20, 1992.A procedure when joining the tail ends of sheet-wound coils stacked one on top of the other around an inductive apparatus core with a certain axial space between them, the joint being effected using a thin leader strip which is connected to adjacent parts of the coils and joined to the coils along almost one coil turn.
Patent AU-8643691-A (AU)
Title: 6- or 7- (2-imino-2-imidazolidine)-1,4-benzoxazines as alpha adrenergic agents
Inventor: GLUCHOWSKI CHARLES
IPC: A61P1/00
Filed: 1991-09-10
Abstract: Compounds having  alpha  adrenergic activity and useful for the treatment of glaucoma, renal and gastrointestinal disorders and vasoconstictors have the formula  <IMAGE>  where R1 is independently H, or lower alkyl or 1 to 6 carbons; R2 is independently H, or lower alkyl of 1 to 6 carbons or the two R2 symbols jointly represent a carbonyl oxygen; R3 is H, lower alkyl of one to 6 carbons, O, OH and OR7 where R7 is lower alkyl of 1 to 6 carbons, or R3 is COH or COR8 where R8 is lower alkyl of 1 to 6 carbons; R4 and R5 independently is H, Br, Cl, or lower alkyl of 1 to 6 carbons, lower alkenyl or lower alkynyl with the proviso that when the R2 groups symbolize a carbonyl oxygen then R4 and R5 both cannot be hydrogen; R6 is hydrogen, Br, Cl, or lower alkyl of 1 to 6 carbons, lower alkenyl or lower alkynyl, and the R5 and the (2-imidazoline-2-yl)amino substituents are connected mutually exclusively to the 6 and 7 positions of the 1,4-benzoxazine nucleus.
Patent AU-8649098-A (AU)
Title: Phenethylamine derivatives
Inventor: KOTAKE KEN-ICHIRO
IPC: C07K5/08
Filed: 1998-08-14
Abstract: Compounds represented by general formula (1) which are phenethylamine derivatives exhibiting a motilin receptor antagonism etc. and being useful as drugs, wherein A represents an amino acid residue, etc.; R1 represents R6 -CO-, etc.; R2 represents hydrogen, etc.; R3 represents -CO-R7 , etc.; R4 represents alkyl, etc.; R5 represents hydroxy, etc.; R6 represents alkyl, etc ; and R7 represents amino, etc. <CHEM>
Patent AU-8900991-A (AU)
Title: Self reinforced composite of thermotropic liquid crystal polymers
Inventor: ISAYEV AVRAAM
IPC: C08J5/04
Filed: 1991-08-15
Abstract: Blend of two or more thermotropic liquid crystal polymers and process for preparing same. Blends of this invention contain at least two, preferably only two, thermotropic liquid crystal polymers which are melt processable. These liquid crystal polymers are wholly aromatic polyesters. At least two polymers in the blend are processable in the melt phase and phase separated in the solid phase. Solid reinforcing agents may be present, but are not necessary and in any case must be in the solid phase at temperatures at which the blend is melt processable. Products of this invention are formed in the melt phase under high strain conditions.